TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 21765126

Group type: EXPERIMENTAL
Intervention: Increasing pump speed (+400 rpm per exercise stage)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Constant pump speed (≈9775 rpm)
Number of subjects: 8
Study: 19747893

Group type: EXPERIMENTAL
Intervention: Colorectal cancer educational video
Number of subjects: 158

Group type: COMPARATOR
Intervention: Non‐medical video
Number of subjects: 158
Study: 17102005

Group type: EXPERIMENTAL
Intervention: ISNT rule assessment in normal eyes
Number of subjects: 109

Group type: COMPARATOR
Intervention: ISNT rule assessment in glaucomatous eyes
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Odds ratio for glaucoma associated with violation of the ISNT rule
Number of subjects: 109
Study: 15633482

Group type: EXPERIMENTAL
Intervention: Whole breast irradiation at 50 Gy (RT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lumpectomy without RT
Number of subjects: 0
Study: 11740347

Group type: EXPERIMENTAL
Intervention: Standard care plus neural mobilization
Number of subjects: 81

Group type: COMPARATOR
Intervention: Standard postoperative care
Number of subjects: 81
Study: 9164414

Group type: EXPERIMENTAL
Intervention: Atovaquone
Number of subjects: 458
Study: 8213508

Group type: EXPERIMENTAL
Intervention: iohexol (Omnipaque 350)
Number of subjects: 1390

Group type: COMPARATOR
Intervention: sodium meglumine diatrizoate (Renografin 76)
Number of subjects: 1390
Study: 3316063

Group type: EXPERIMENTAL
Intervention: Subliminal exposure to the message 'MOMMY AND I ARE ONE' (experimental group)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Subliminal exposure to the message 'PEOPLE ARE WALKING' (control group)
Number of subjects: 47
Study: 29723592

Group type: EXPERIMENTAL
Intervention: Reduced Activity Group (N = 19)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control Group (N = 20)
Number of subjects: 39
Study: 27871268

Group type: EXPERIMENTAL
Intervention: Metformin (500 mg oral tablets, increasing to a maximum of 1000 mg twice daily)
Number of subjects: 524

Group type: COMPARATOR
Intervention: Placebo (identical appearing and tasting tablets)
Number of subjects: 524
Study: 25372087

Group type: EXPERIMENTAL
Intervention: Screening with low-dose CT
Number of subjects: 0

Group type: COMPARATOR
Intervention: Screening with radiography
Number of subjects: 0

Group type: COMPARATOR
Intervention: No screening
Number of subjects: 0
Study: 23742102

Group type: EXPERIMENTAL
Intervention: EpiFix (dehydrated human amniotic membrane allografts) with standard care
Number of subjects: 25

Group type: COMPARATOR
Intervention: Standard care alone
Number of subjects: 25
Study: 21338205

Group type: EXPERIMENTAL
Intervention: Knowledge of risk factors for oral cancer (tobacco and alcohol)
Number of subjects: 238

Group type: EXPERIMENTAL
Intervention: Knowledge of signs of oral cancer (white and red lesions)
Number of subjects: 238

Group type: EXPERIMENTAL
Intervention: Higher knowledge of risk factors
Number of subjects: 238
Study: 18959679

Group type: EXPERIMENTAL
Intervention: iNO + Mil (iNO at approximately 10 ppm and milrinone at 0.5 microg/kg/min)
Number of subjects: 31

Group type: COMPARATOR
Intervention: iNO
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: iNO + Mil
Number of subjects: 31
Study: 15879165

Group type: EXPERIMENTAL
Intervention: Isometric contraction at 20% of maximal voluntary contraction (MVC) torque
Number of subjects: 16
Study: 12859441

Group type: EXPERIMENTAL
Intervention: Parietaria SIT
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 10720167

Group type: EXPERIMENTAL
Intervention: Egg white-tryptophan
Number of subjects: 30

Group type: COMPARATOR
Intervention: Milk
Number of subjects: 30
Study: 8863936

Group type: EXPERIMENTAL
Intervention: Occupationally embedded exercise (dice game)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Rote exercise (no game)
Number of subjects: 26
Study: 1380197

Group type: EXPERIMENTAL
Intervention: Total body cryotherapy
Number of subjects: 8

Group type: COMPARATOR
Intervention: Whole spine paraffin mud packs
Number of subjects: 8
Study: 6831836

Group type: EXPERIMENTAL
Intervention: L‐adrenaline 0.025 micrograms min‐1 kg‐1
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: L‐adrenaline 0.05 micrograms min‐1 kg‐1
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 30638738

Group type: EXPERIMENTAL
Intervention: Essential amino acid-enriched meal replacement (EMR)
Number of subjects: 8

Group type: COMPARATOR
Intervention: High-protein meal replacement beverage (Bariatric Advantage, BA)
Number of subjects: 8
Study: 28350273

Group type: EXPERIMENTAL
Intervention: OTSC
Number of subjects: 22

Group type: COMPARATOR
Intervention: Padlock
Number of subjects: 22
Study: 25550337

Group type: EXPERIMENTAL
Intervention: 10 mg/kg abatacept
Number of subjects: 108

Group type: COMPARATOR
Intervention: 5 mg/kg abatacept
Number of subjects: 108
Study: 24135087

Group type: EXPERIMENTAL
Intervention: Low glycaemic index meal (GI 37)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: High glycaemic index meal (GI 73)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control (not specified, but implied as standardised premeal and fasting)
Number of subjects: 10
Study: 21279703

Group type: EXPERIMENTAL
Intervention: Weekly low-dose gemcitabine (100 mg/m² over 30 min 1-2 h before radiotherapy)
Number of subjects: 216

Group type: COMPARATOR
Intervention: Weekly low-dose paclitaxel (20 mg/m² over 60 min 4-6 h before radiotherapy)
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Weekly low-dose gemcitabine
Number of subjects: 216

Group type: COMPARATOR
Intervention: Weekly low-dose paclitaxel
Number of subjects: 216
Study: 19453519

Group type: EXPERIMENTAL
Intervention: Autologous chondrocyte implantation and combination products; specific dosage and duration not mentioned.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Growth factor research; specific details not mentioned.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cellular and molecular studies using new technologies; specific details not mentioned.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Careful selection of patient groups; specific details not mentioned.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Study outcome parameters; specific details not mentioned.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Reduced pain and improved function; specific details not mentioned.
Number of subjects: 0
Study: 17549880

Group type: EXPERIMENTAL
Intervention: Training for fathers, details on dosage and duration not available
Number of subjects: 0

Group type: COMPARATOR
Intervention: Absence of a father-figure
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fatherhood as a factor of male personality development
Number of subjects: 0
Study: 15651990

Group type: EXPERIMENTAL
Intervention: Multidisciplinary intervention programme
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 0
Study: 14592254

Group type: EXPERIMENTAL
Intervention: Pergolide
Number of subjects: 15
Study: 10101624

Group type: EXPERIMENTAL
Intervention: Caudal anaesthesia with bupivacaine 0.25% 1 mL kg‐1 combined with general anaesthesia but without opioids
Number of subjects: 40

Group type: COMPARATOR
Intervention: General anaesthesia including intravenous fentanyl
Number of subjects: 40
Study: 8789469

Group type: EXPERIMENTAL
Intervention: Heparin-coated circuits (group HC)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (group C)
Number of subjects: 20
Study: 2263886

Group type: EXPERIMENTAL
Intervention: K-pouch
Number of subjects: 55

Group type: COMPARATOR
Intervention: J-pouch
Number of subjects: 55
Study: 383195

Group type: EXPERIMENTAL
Intervention: Buprenorphine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Diamorphine
Number of subjects: 0
Study: 31754697

Group type: EXPERIMENTAL
Intervention: DHA supplementation
Number of subjects: 110

Group type: COMPARATOR
Intervention: Control group (no DHA supplementation)
Number of subjects: 110
Study: 31152327

Group type: COMPARATOR
Intervention: Anastrozole (A)
Number of subjects: 870

Group type: EXPERIMENTAL
Intervention: Fulvestrant plus Anastrozole (A + F)
Number of subjects: 870
Study: 27836979

Group type: EXPERIMENTAL
Intervention: Mild ovarian stimulation strategy (low-dose gonadotropins 150 IU FSH, GnRH-antagonist)
Number of subjects: 394

Group type: COMPARATOR
Intervention: Conventional ovarian stimulation strategy (high-dose gonadotropins 450 IU HMG, long mid-luteal GnRH-agonist)
Number of subjects: 394

Group type: EXPERIMENTAL
Intervention: Mild ovarian stimulation strategy
Number of subjects: 394
Study: 26001819

Group type: EXPERIMENTAL
Intervention: Everolimus-eluting stent (EES)
Number of subjects: 1509

Group type: COMPARATOR
Intervention: Sirolimus-eluting stent (SES)
Number of subjects: 1509

Group type: COMPARATOR
Intervention: Paclitaxel-eluting stent
Number of subjects: 1509
Study: 23041709

Group type: EXPERIMENTAL
Intervention: Basic (training and curriculum only)
Number of subjects: 2841

Group type: EXPERIMENTAL
Intervention: Basic Plus (training and curriculum plus CATCH facilitator support)
Number of subjects: 2841

Group type: EXPERIMENTAL
Intervention: Basic Plus Social Marketing (all inputs plus social marketing component)
Number of subjects: 2841

Group type: COMPARATOR
Intervention: Control group (not explicitly defined in the abstract)
Number of subjects: 2841
Study: 21345699

Group type: EXPERIMENTAL
Intervention: 6% HES130/0.4 balanced (Volulyte)
Number of subjects: 81

Group type: COMPARATOR
Intervention: 6% HES130/0.4 saline (Voluven)
Number of subjects: 81
Study: 19732667

Group type: EXPERIMENTAL
Intervention: Self-ligating bracket system (SmartClip, 3M Unitek)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional preadjusted edgewise brackets (Victory, 3M Unitek)
Number of subjects: 60
Study: 17215757

Group type: EXPERIMENTAL
Intervention: With Alexis retractor
Number of subjects: 221

Group type: COMPARATOR
Intervention: Without Alexis retractor
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: With Alexis retractor (colorectal surgery subgroup)
Number of subjects: 221
Study: 15225887

Group type: EXPERIMENTAL
Intervention: Methadone (METH)
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Buprenorphine (BUP)
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Methadone (METH) and Buprenorphine (BUP)
Number of subjects: 154
Study: 11463927

Group type: EXPERIMENTAL
Intervention: Vaginal douching (general)
Number of subjects: 543

Group type: EXPERIMENTAL
Intervention: Douching with soap and water
Number of subjects: 543

Group type: EXPERIMENTAL
Intervention: Frequency of douching
Number of subjects: 543

Group type: EXPERIMENTAL
Intervention: Douching
Number of subjects: 543
Study: 9555597

Group type: EXPERIMENTAL
Intervention: ondansetron 2 mg twice daily
Number of subjects: 108

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 108
Study: 7990068

Group type: EXPERIMENTAL
Intervention: Psychological preparation
Number of subjects: 74

Group type: COMPARATOR
Intervention: No-treatment control procedure
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Not applicable
Number of subjects: 74
Study: 2688602

Group type: EXPERIMENTAL
Intervention: Captopril 25 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 790552

Group type: EXPERIMENTAL
Intervention: Aspirin (3.6 g daily)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Ketoprofen (200 mg daily)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 31639265

Group type: EXPERIMENTAL
Intervention: Audiovisual information
Number of subjects: 300

Group type: COMPARATOR
Intervention: Verbal information
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 300
Study: 28168769

Group type: EXPERIMENTAL
Intervention: 0.1% TAC ointment (n = 11)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: 0.1% TRI paste (n = 7)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Orabase® paste as PLA (n = 9)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Comparison between TAC and TRI
Number of subjects: 27
Study: 25798680

Group type: EXPERIMENTAL
Intervention: Recipient pretransplant vaccination
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Donor pretransplant vaccination
Number of subjects: 122

Group type: COMPARATOR
Intervention: No pretransplant vaccination
Number of subjects: 122
Study: 22740153

Group type: EXPERIMENTAL
Intervention: RFVTR (bipolar radiofrequency volumetric tissue reduction)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 21266004

Group type: EXPERIMENTAL
Intervention: Local and intraarticular analgesic injection (LIA) composed of 5 mg morphine, 30 mg bupivacaine (15 mg/1.5 mL), 1 mL betamethasone, and 0.5 mL epinephrine (1:1,000)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Local and intraarticular analgesic injection (LIA)
Number of subjects: 80
Study: 19432231

Group type: EXPERIMENTAL
Intervention: Vitaprost tablets
Number of subjects: 0
Study: 16422733

Group type: EXPERIMENTAL
Intervention: 4-cm thermoactive viscoelastic foam overlay with a water-filled warming mattress
Number of subjects: 175

Group type: COMPARATOR
Intervention: Standard operating room table with a water-filled warming mattress (no pressure-reducing device)
Number of subjects: 175
Study: 12921815

Group type: EXPERIMENTAL
Intervention: Hydrotherapy (n=15)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group (n=10)
Number of subjects: 25
Study: 10855070

Group type: EXPERIMENTAL
Intervention: Shouldice's repair (SR)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Moloney's darn repair (DR)
Number of subjects: 50
Study: 9236504

Group type: EXPERIMENTAL
Intervention: Treatment with nasal saline, sulfamethoxazole‐trimethoprim, antihistamine/decongestant, and five days of prednisone.
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control group (non-treatment control).
Number of subjects: 66
Study: 1548713

Group type: EXPERIMENTAL
Intervention: Pharyngeotracheal lumen airway (PtL)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Endotracheal tube (ET)
Number of subjects: 111
Study: 2865614

Group type: EXPERIMENTAL
Intervention: Podophyllin application
Number of subjects: 60

Group type: COMPARATOR
Intervention: Surgical excision
Number of subjects: 60
Study: 28931460

Group type: EXPERIMENTAL
Intervention: 2 weeks of computerized EF training (1h sessions 3 times per week and 40min daily home training)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control training
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: 2 weeks of computerized EF training
Number of subjects: 25
Study: 29881465

Group type: EXPERIMENTAL
Intervention: Prefabricated foot orthoses
Number of subjects: 160

Group type: COMPARATOR
Intervention: Customised foot orthoses
Number of subjects: 160
Study: 26953193

Group type: EXPERIMENTAL
Intervention: Isavuconazole (prodrug isavuconazonium sulfate); administered intravenously and orally; specific dosage and duration not mentioned
Number of subjects: 0

Group type: COMPARATOR
Intervention: Healthy subjects; control group
Number of subjects: 0
Study: 24331121

Group type: EXPERIMENTAL
Intervention: L-PRF (N = 10)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (N = 10)
Number of subjects: 20
Study: 22183840

Group type: EXPERIMENTAL
Intervention: Episodic acyclovir therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 20174641

Group type: EXPERIMENTAL
Intervention: Recognition of items as old in the presence of four confederates during the long version of the experiment.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Recognition of items as old in the presence of four confederates during the short version of the experiment.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rejection of new items in the presence of four confederates during the short version of the experiment.
Number of subjects: 0
Study: 17712576

Group type: EXPERIMENTAL
Intervention: Surgical intervention (operated group)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Conservative treatment (non-operated group)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Cerebrospinal fluid NO(x) levels
Number of subjects: 25
Study: 11343441

Group type: EXPERIMENTAL
Intervention: Systolic Blood Pressure (SBP)
Number of subjects: 5888

Group type: EXPERIMENTAL
Intervention: Diastolic Blood Pressure (DBP)
Number of subjects: 5888

Group type: EXPERIMENTAL
Intervention: Pulse Pressure
Number of subjects: 5888

Group type: EXPERIMENTAL
Intervention: Systolic Blood Pressure (SBP) in treated hypertension
Number of subjects: 5888
Study: 9757895

Group type: EXPERIMENTAL
Intervention: Double centrifugation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multiple-tube swim-up
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Percoll density gradient
Number of subjects: 0
Study: 8110548

Group type: EXPERIMENTAL
Intervention: Sufentanil at a plasma concentration of 0.145 ng ml‐1
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Sufentanil at a plasma concentration greater than 0.5 ng ml‐1
Number of subjects: 76

Group type: COMPARATOR
Intervention: Plasma fentanyl concentration of 1.67 ng ml‐1
Number of subjects: 76
Study: 3409138

Group type: EXPERIMENTAL
Intervention: Active drug
Number of subjects: 0

Group type: COMPARATOR
Intervention: Matched placebo
Number of subjects: 0
Study: 30900980

Group type: EXPERIMENTAL
Intervention: ethinyl estradiol 0.02 mg + levonorgestrel 0.10 mg + folic acid 0.4 mg
Number of subjects: 36

Group type: COMPARATOR
Intervention: placebo coated tablet containing folic acid 0.4 mg only
Number of subjects: 36
Study: 27774892

Group type: EXPERIMENTAL
Intervention: ATV+COBI
Number of subjects: 692

Group type: COMPARATOR
Intervention: ATV+RTV
Number of subjects: 692
Study: 26442402

Group type: EXPERIMENTAL
Intervention: Listening to recordings of their mothers' heartbeat and womb sounds via earphones during anaesthesia induction
Number of subjects: 40

Group type: COMPARATOR
Intervention: Ambient noise via earphones
Number of subjects: 40
Study: 23636760

Group type: EXPERIMENTAL
Intervention: 6‐mm lateral wedge condition
Number of subjects: 9

Group type: COMPARATOR
Intervention: 6‐mm medial wedge condition
Number of subjects: 9
Study: 21767403

Group type: EXPERIMENTAL
Intervention: IPTi with Sulfadoxine-Pyrimethamine (SP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (non-IPTi zone)
Number of subjects: 0
Study: 19567496

Group type: EXPERIMENTAL
Intervention: C-Flex (110 patients)
Number of subjects: 218

Group type: COMPARATOR
Intervention: CPAP (108 patients)
Number of subjects: 218

Group type: COMPARATOR
Intervention: CPAP therapy (< 4 h of use)
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: C-Flex and CPAP
Number of subjects: 218
Study: 16357312

Group type: EXPERIMENTAL
Intervention: Rosiglitazone 8 mg daily
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 15108041

Group type: EXPERIMENTAL
Intervention: Immunochemotherapy group (MMC + 5‐FU + HCFU + OK‐432)
Number of subjects: 1429

Group type: EXPERIMENTAL
Intervention: Chemotherapy group (MMC + 5‐FU + HCFU)
Number of subjects: 1429

Group type: COMPARATOR
Intervention: Control group (surgery alone)
Number of subjects: 1429

Group type: EXPERIMENTAL
Intervention: Immunochemotherapy group (MMC + 5‐FU + UFT + OK‐432)
Number of subjects: 1429

Group type: EXPERIMENTAL
Intervention: Chemotherapy group (MMC + 5‐FU + UFT)
Number of subjects: 1429
Study: 11018229

Group type: EXPERIMENTAL
Intervention: Family-focused psychoeducational treatment (FFT) - 21 sessions over 9 months
Number of subjects: 101

Group type: COMPARATOR
Intervention: Comparison treatment (CM) - 2 family education sessions and follow-up crisis management over 9 months
Number of subjects: 101
Study: 9066316

Group type: COMPARATOR
Intervention: Fentanyl (2 micrograms.kg.‐1. min‐1)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Remifentanil (1 mu.kg‐1.min‐1)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Fentanyl
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Remifentanil
Number of subjects: 63
Study: 8364194

Group type: EXPERIMENTAL
Intervention: 1 g/kg body weight i.v. IgG infusion
Number of subjects: 20

Group type: COMPARATOR
Intervention: 2 g/kg body weight i.v. IgG infusion
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: six 1 g/kg body weight i.v. IgG reinfusions
Number of subjects: 20
Study: 31154891

Group type: EXPERIMENTAL
Intervention: Intoxicated condition (after smoking cannabis)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Non-intoxicated condition (free from cannabinoids for at least one week)
Number of subjects: 19
Study: 28284202

Group type: EXPERIMENTAL
Intervention: Integrated care model including a multidisciplinary team and continuous care coordination
Number of subjects: 5462

Group type: EXPERIMENTAL
Intervention: Integrated care model and provider‐level financial incentives
Number of subjects: 5462

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 5462
Study: 26165216

Group type: EXPERIMENTAL
Intervention: Botulinum toxin A (BTX) injections
Number of subjects: 16

Group type: COMPARATOR
Intervention: Saline (NaCl) injections
Number of subjects: 16
Study: 23458232

Group type: EXPERIMENTAL
Intervention: 2-day parental education program (PEP)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Conventional treatment alone (Control)
Number of subjects: 59
Study: 21807618

Group type: EXPERIMENTAL
Intervention: Localized BH(4)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Combo (arginase inhibited + BH(4)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Atorvastatin intervention (10 mg for 3 months)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Localized BH(4) after atorvastatin
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Combo after atorvastatin
Number of subjects: 18
Study: 19896021

Group type: EXPERIMENTAL
Intervention: Low-literacy medication education tool
Number of subjects: 166

Group type: COMPARATOR
Intervention: Control group (standard discharge instructions)
Number of subjects: 166
Study: 17005501

Group type: COMPARATOR
Intervention: Aerobic exercise
Number of subjects: 60

Group type: COMPARATOR
Intervention: Resistance exercise
Number of subjects: 60
Study: 15175214

Group type: EXPERIMENTAL
Intervention: Topical lidocaine 2% gel
Number of subjects: 36

Group type: COMPARATOR
Intervention: Intraurethral lubrication only (Control)
Number of subjects: 36
Study: 11416115

Group type: EXPERIMENTAL
Intervention: H. pylori positive (including CagA+ strains)
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: CagA+ strains
Number of subjects: 121

Group type: COMPARATOR
Intervention: Control (H. pylori negative)
Number of subjects: 121
Study: 9296514

Group type: EXPERIMENTAL
Intervention: Vaccinia melanoma oncolysate (VMO) vaccine
Number of subjects: 217

Group type: COMPARATOR
Intervention: Placebo vaccinia vaccine virus (V)
Number of subjects: 217
Study: 8370370

Group type: EXPERIMENTAL
Intervention: Nicorandil, 20 mg b.d.
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Diltiazem, 60 mg t.d.
Number of subjects: 123